Sep 10, 2025 4:05 pm EDT LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions
Sep 3, 2025 8:00 am EDT LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer
Aug 13, 2025 7:30 am EDT LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency
Jul 16, 2025 8:05 am EDT LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements
Jul 9, 2025 8:05 am EDT New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
Jul 8, 2025 4:05 pm EDT Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
Jul 2, 2025 4:05 pm EDT Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
Jul 1, 2025 4:15 pm EDT Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
Mar 31, 2025 8:30 am EDT LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
